UNICREDIT BANK/CALL/AMGEN/380/0.1/17.12.25 | Market Closed - BOERSE MUENCHEN 15:41:31 2024-05-31 EDT | ||
| 1.81 EUR | +4.02% |
|
| 1 month | +84.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 1.81 | +4.02% |
| 24-05-30 | 1.74 | +7.41% |
| 24-05-29 | 1.62 | -5.81% |
| 24-05-28 | 1.72 | -8.99% |
| 24-05-27 | 1.89 | -1.05% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 03:41 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD4WEN |
| ISIN | DE000HD4WEN8 |
| Date issued | 2024-04-22 |
| Strike | 380 $ |
| Maturity | 2025-12-17 (564 Days) |
| Parity | 10 : 1 |
| Emission price | 1.12 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.36 € |
|---|---|
| Lowest since issue | 0.82 € |
| Delta | 0.34x |
| Omega | 5.191 |
| Premium | 30.88x |
| Gearing | 15.11x |
| Moneyness | 0.8047 |
| Difference Strike | 74.2 $ |
| Difference Strike % | +19.53% |
| Spread | 0.05 € |
| Spread % | 2.65% |
| Theoretical value | 1.875 |
| Implied Volatility | 27.25 % |
| Total Loss Probability | 75.86 % |
| Intrinsic value | 0.000000 |
| Present value | 1.875 |
| Break even | 400.34 € |
| Theta | -0.02x |
| Vega | 0.13x |
| Rho | 0.12x |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Warrants
- Warrant
